Showing results (1341-1350 of 2,818) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|March 5, 2026
Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT TrialMarcus C Ward, Alisa Boucsein, Yongwen Zhou, et al.
Diabetes Technology & Therapeutics|March 2, 2026
Impact of Continuous Glucose Monitor on Health Care Resource Utilization in Adults with Type 2 Diabetes Managed by Noninsulin TherapiesAnup K Sharma, Abraham Lee, Shivani Mehta, et al.
Diabetes Technology & Therapeutics|February 20, 2024
Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 DiabetesGregory P Forlenza, Daniel J DeSalvo, Grazia Aleppo, et al.
Diabetes Technology & Therapeutics|February 20, 2024
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery SystemsHalis K Akturk, Tadej Battelino, Javier Castañeda, et al.
Diabetes Technology & Therapeutics|February 20, 2024
Exercising Safely with the MiniMed™ 780G Automated Insulin Delivery SystemDavid N O'Neal, Dessi P Zaharieva, Dale Morrison, et al.
Diabetes Technology & Therapeutics|March 21, 2024
Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 DiabetesSatish K Garg, Halis K Akturk, Gurleen Kaur, et al.
Diabetes Technology & Therapeutics|March 21, 2024
Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal InsulinsRobbe De Groote, Eveline Lefever, Sara Charleer, et al.
Diabetes Technology & Therapeutics|February 22, 2024
Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched StudySara Charleer, Steffen Fieuws, Christophe De Block, et al.
Diabetes Technology & Therapeutics|February 20, 2024
Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical EvidencePratik Choudhary, Arcelia Arrieta, Tim van den Heuvel, et al.
Diabetes Technology & Therapeutics|March 6, 2024
Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 DiabetesTimothy C Dunn, Ramzi A Ajjan, Richard M Bergenstal, et al.
Pageof 282